Novel breast cancer metastasis-associated proteins

Journal of Proteome Research

Volumn 8, Issue 2, 2009, Pages 583-594

  Ho, Jiapei ^a   Kong, Jacklyn Wai Fun ^a   Choong, Lee Yee ^a   Loh, Marie Chiew Shia ^b   Toy, Weiyl ^a   Chong, Poh Kuan ^a   Wong, Chee Hong ^b   Wong, Chow Yin ^c   Shah, Nilesh ^a   Lim, Yoon Pin ^a,b,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b BIOINFORMATICS INSTITUTE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d Centre for Life Sciences   (Singapore)

Author keywords

Breast cancer; Metastasis; Proteomics; Tissue microarray

Indexed keywords

PHOSPHATASE; PHOSPHOTRANSFERASE; PROTEIN SH3GLB1; PROTEIN SND1; PROTEIN SUB1; PROTEIN TRIM28; PROTEINASE; TRANSCRIPTION FACTOR; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST METASTASIS; CELL METABOLISM; CONTROLLED STUDY; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ORTHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROTEIN ARRAY ANALYSIS; REPRODUCIBILITY OF RESULTS; TISSUE ARRAY ANALYSIS;

EID: 61849154412     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr8007368     Document Type: Article

References (41)

1. Sahai, E. Illuminating the metastatic process. Nat. Rev. Cancer 2007, 7 (10), 737-749.
2. Zidan, J.; Dashkovsky, I.; Stayerman, C.; Basher, W.; Cozacov, C.; Hadary, A. Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease. Br. J. Cancer 2005, 93 (5), 552-556.
3. Pantel, K.; Cote, R. J.; Fodstad, O. Detection and clinical importance of micrometastatic disease. J. Natl. Cancer Inst. 1999, 91 (13), 1113- 1124.
4. Ramaswamy, S.; Ross, K. N.; Lander, E. S.; Golub, T. R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 2003, 33 (1), 49-54.
5. van't Veer, L. J.; Dai, H.; van deVijver, M. J.; He, Y. D.; Hart, A. A.; Mao, M.; Peterse, H. L.; vanderKooy, K.; Marton, M. J.; Witteveen, A. T.; Schreiber, G. J.; Kerkhoven, R. M.; Roberts, C.; Linsley, P. S.; Bernards, R.; Friend, S. H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415 (6871), 530- 536.
6. Minn, A. J.; Gupta, G. P.; Siegel, P. M.; Bos, P. D.; Shu, W.; Giri, D. D.; Viale, A.; Olshen, A. B.; Gerald, W. L.; Massague, J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436 (7050), 518-524.
7. Kreunin, P.; Yoo, C.; Urquidi, V.; Lubman, D. M.; Goodison, S. Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model. Proteomics 2007, 7 (2), 299-312.
8. Aslakson, C. J.; Miller, F. R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 1992, 52 (6), 1399-1405.
9. Aslakson, C. J.; Rak, J. W.; Miller, B. E.; Miller, F. R. Differential influence of organ site on three subpopulations of a single mouse mammary tumor at two distinct steps in metastasis. Int. I. Cancer 1991, 47 (3), 466-472.
10. Yang, J.; Mani, S. A.; Donaher, J. L.; Ramaswamy, S.; Itzykson, R. A.; Come, C.; Savagner, P.; Gitelman, I.; Richardson, A.; Weinberg, R. A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117 (7), 927-939.
11. Hosono, S.; Kajiyama, H.; Terauchi, M.; Shibata, K.; Ino, K.; Nawa, A.; Kikkawa, F. Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients. Br. J. Cancer 2007, 96 (2), 314-320.
12. Shadidi, M.; Sorensen, D.; Dybwad, A.; Furset, G.; Sioud, M. Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma. Int. J. Oncol. 2008, 32 (1), 241-247.
13. Tang, B.; Vu, M.; Booker, T.; Santner, S. J.; Miller, F. R.; Anver, M. R.; Wakefield, L. M. TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J. Clin. Invest. 2003, 112 (7), 1116-1124.
14. Elias, J. E.; Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 2007, 4 (3), 207-214.
15. Lim, Y. P.; Diong, L. S.; Qi, R.; Druker, B. J.; Epstein, R. J. Phosphoproteomic fingerprinting of epidermal growth factor signaling and anticancer drug action in human tumor cells. Mol. Cancer Ther. 2003, 2 (12), 1369-1377.
16. Lim, Y. P.; Low, B. C.; Lim, J.; Wong, E. S.; Guy, G. R. Association of atypical protein kinase C isotypes with the docker protein FRS2 in fibroblast growth factor signaling. J. Biol. Chem. 1999, 274 (27), 19025-19034.
17. Chen, Y.; Choong, L. Y.; Lin, Q.; Philp, R.; Wong, C. H.; Ang, B. K.; Tan, Y. L.; Loh, M. C.; Hew, C. L.; Shah, N.; Druker, B. J.; Chong, P. K.; Lim, Y. P. Differential expression of novel tyrosine kinase substrates during breast cancer development. Mol. Cell Proteomics 2007, 6 (12), 2072-2087.
18. Gan, C. S.; Chong, P. K.; Pham, T. K.; Wright, P. C. Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ). J. Proteome Res. 2007, 6 (2), 821-827.
19. Kroemer, G.; Pouyssegur, J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008, 13 (6), 472-482.
20. Lee, J. W.; Jeong, E. G.; Soung, Y. H.; Nam, S. W.; Lee, J. Y.; Yoo, N. J.; Lee, S. H. Decreased expression of tumour suppressor Bax- interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas. Pathology 2006, 38 (4), 312-315.
21. Tsuchiya, N.; Ochiai, M.; Nakashima, K.; Ubagai, T.; Sugimura, T.; Nakagama, H. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis. Cancer Res. 2007, 67 (19), 9568- 9576.
22. Yu, P.; Huang, B.; Shen, M.; Lau, C.; Chan, E.; Michel, J.; Xiong, Y.; Payan, D. G.; Luo, Y. pl5(PAF), a novel PCNA associated factor with increased expression in tumor tissues. Oncogene 2001, 20 (4), 484-489.
23. Pedersen, N.; Mortensen, S.; Sorensen, S. B.; Pedersen, M. W.; Rieneck, K.; Bovin, L. F.; Poulsen, H. S. Transcriptional gene expression profiling of small cell lung cancer cells. Cancer Res. 2003, 63 (8), 1943-1953.
24. Takahashi, Y.; Karbowski, M.; Yamaguchi, H.; Kazi, A.; Wu, J.; Sebti, S. M.; Youle, R. J.; Wang, H. G. Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis. Mol. Cell. Biol. 2005, 25 (21), 9369-9382.
25. Carujo, S.; Estanyol, J. M.; Ejarque, A.; Agell, N.; Bachs, O.; Pujol, M. J. Glyceraldehyde 3-phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdkl activity. Oncogene 2006, 25 (29), 4033-4042.
26. Du, Z.-X; Wang, H.-Q.; Zhang, H.-Y.; Gao, D.-X. Involvement of glyceraldehyde-3-phosphate dehydrogenase in tumor necrosis factor-related apoptosis-inducing ligand-mediated death of thyroid cancer cells. Endocrinology 2007, 148 (9), 4352-4361.
27. Sweeney, K. J.; Clark, G. D.; Prokscha, A.; Dobyns, W. B.; Eichele, G. Lissencephaly associated mutations suggest a requirement for the PAFAH1B heterotrimeric complex in brain development. Mech. Dev. 2000, 92 (2), 263-271.
28. Tan, I.; Ng, C. H.; Lim, L.; Leung, T. Phosphorylation of a novel myosin binding subunit of protein phosphatase 1 reveals a conserved mechanism in the regulation of actin cytoskeleton. J. Biol. Chem. 2001, 276 (24), 21209-21216.
29. Lee, J. W.; Jeong, E. G.; Soung, Y. H.; Nam, S. W.; Lee, J. Y.; Yoo, N. J.; Lee, S. H. Decreased expression of tumour suppressor Bax- interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas. Pathology 2006, 38 (4), 312-315.
30. Cuddeback, S. M.; Yamaguchi, H.; Komatsu, K.; Miyashita, T.; Yamada, M.; Wu, C.; Singh, S.; Wang, H.-G. Molecular cloning and characterization of Bif-1. A novel Src homology 3 domain- containing protein that associates with Bax. J. Biol. Chem. 2001, 276 (23), 20559-20565.
31. Arruda-Carvalho, M.; Njaine, B.; Silveira, M. S.; Linden, R.; Chiarini, L. B. Hop/STIl modulates retinal proliferation and cell death independent of PrPC. Biochem. Biophys. Res. Commun. 2007, 361 (2), 474-480.
32. Erlich, R. B.; Kahn, S. A.; Lima, F. R.; Muras, A. G.; Martins, R. A.; Linden, R.; Chiarini, L. B.; Martins, V. R.; Moura Neto, V. STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia 2007, 55 (16), 1690-1698.
33. Das, C.; Hizume, K.; Batta, K.; Kumar, B. R. P.; Gadad, S. S.; Ganguly, S.; Lorain, S.; Verreault, A.; Sadhale, P. P.; Takeyasu, K.; Kundu, T. K. Transcriptional Coactivator PC4, a Chromatin- Associated Protein, Induces Chromatin Condensation. Mol. Cell. Biol. 2006, 26 (22), 8303-8315.
34. Wang, C, I. A.; Chen, L.; Fredericks, W. J.; Seto, E.; Rauscher, F. J., III.; Chen, J. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J. 2005, 24, 3279-3290.
35. Lee, Y.-K.; Thomas, S. N.; Yang, A. J.; Ann, D. K. Doxorubicin down- regulates Kruppel-associated Box domain-associated protein 1 sumoylation that relieves its transcription repression on p21WAFl/ CIP1 in breast cancer MCF-7 cells. J. Biol. Chem. 2007, 282 (3), 1595-1606.
36. Tsuchiya, N.; Ochiai, M.; Nakashima, K.; Ubagai, T.; Sugimura, T.; Nakagama, H. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis. Cancer Res. 2007, 67 (19), 9568- 9576.
37. Broadhurst, M. K.; Lee, R. S. F.; Hawkins, S.; Wheeler, T. T. The p100 EBNA-2 coactivator a highly conserved protein found in a range of exocrine and endocrine cells and tissues in cattle. Biochim. Biophys Acta 2005, 1681 (2-3), 126-133.
38. Chistiakov, D. A.; Seryogin, Y. A; Turakulov, R. I.; Savost'anov, K. V.; Titovich, E. V.; Zilberman, L. I.; Kuraeva, T. L.; Dedov, I.I.; Nosikov, V. V. Evaluation of IDDM8 susceptibility locus in a Russian simplex family data set. J. Autoimmun. 2005, 24 (3), 243-250.
39. Weiske, J.; Huber, O. The histidine triad protein Hintl Triggers apoptosis independent of its enzymatic activity. J. Biol. Chem. 2006, 281 (37), 27356-27366.
40. Wang, L.; Zhang, Y.; Li, H.; Xu, Z.; Santella, R. M.; Weinstein, I. B. Hintl inhibits growth and activator protein-1 activity in human colon cancer cells. Cancer Res. 2007, 67 (10), 4700-4708.
41. Tao, zfn > S.; Masumi, S.; Lei, W.; ChyuanSheng, L.; WangQiu, X; IB, W. Deletion of histidine triad nucleotide-binding protein 1/PKC-interacting protein in mice enhances cell growth and carcinogenesis. Proc. Natl. Acad. Sci. U.SA. 2003, 100 (13), 7824-7829.